Shareholders Approve SL Bio Business Combination and Extend Deadline to February 2027

summarizeSummary

Shareholders of Horizon Space Acquisition II Corp. approved the business combination with SL Bio and extended the deadline to complete the merger until February 2027, providing a clear path forward for the SPAC.

check_boxKey Events

• Business Combination Approved

  Shareholders approved the Business Combination Agreement with SL Science Holding Limited (PubCo) and SL BIO Ltd., moving the company closer to completing its merger.

• Deadline Extended to February 2027

  Shareholders approved amendments to the Articles of Association and the Investment Management Trust Agreement, extending the deadline to complete a business combination from February 18, 2026, to February 18, 2027.

• New Director Appointed

  William Wang Ching-Dong was approved as the sole director of HSPT, effective upon the First Merger Effective Time.

auto_awesomeAnalysis

Horizon Space Acquisition II Corp. shareholders have approved the proposed business combination with SL Bio, a critical step for the SPAC to complete its de-SPAC transaction. Concurrently, shareholders also approved an extension of the deadline to complete a business combination until February 18, 2027. This dual approval provides the company with both the mandate to proceed with the merger and additional time to finalize the transaction, mitigating immediate liquidation risk. The appointment of a new sole director effective upon merger completion further signals progress towards the combined entity.